Circadian rhythm disruption is a prevalent and underrecognized feature of progressive supranuclear palsy (PSP), contributing to sleep-wake cycle disturbances, cognitive decline, and overall disease progression. The suprachiasmatic nucleus (SCN) and its downstream melatonin signaling pathways represent key sites of vulnerability in PSP pathophysiology.
The circadian system in mammals comprises:
- Suprachiasmatic nucleus (SCN) — master circadian clock in the hypothalamus
- Melatonin synthesis — primarily from the pineal gland, regulated by SCN
- Peripheral clocks — present in most organs and tissues
- Entraining cues — light, feeding, temperature, and melatonin
In PSP, tau pathology invades the SCN and related hypothalamic structures, disrupting circadian timekeeping. Additionally, pineal gland dysfunction reduces melatonin output, further compromising circadian alignment.
The suprachiasmatic nucleus is particularly vulnerable to tau pathology in PSP:
| Finding |
Evidence |
| SCN neuronal loss |
Postmortem studies show 30-50% neuronal loss in PSP |
| Tau inclusion formation |
4R-tau inclusions documented in SCN neurons |
| Neuroinflammation |
Activated microglia surrounding SCN |
| Functional disconnection |
Loss of SCN output to peripheral clocks |
The SCN contains approximately 20,000 neurons that generate circadian rhythms in locomotor activity, sleep-wake cycles, hormone secretion, and body temperature. Tau-mediated SCN degeneration in PSP disrupts these coordinated rhythms[^song2019].
¶ Pineal Gland Dysfunction
The pineal gland produces melatonin, the "hormone of darkness" that:
- Signals nighttime to peripheral tissues
- Enhances sleep quality and glymphatic clearance
- Provides antioxidant protection to neurons
- Modulates immune function
In PSP, pineal gland involvement includes:
- Reduced melatonin secretion — documented in PSP patients vs. age-matched controls[^videnovic2014]
- Calcification acceleration — age-related pineal calcification is enhanced[^lamorgia2018]
- Tau pathology in pinealocytes — occasional inclusion formation
- Disrupted melatonin rhythm — loss of normal nocturnal surge
A key mechanism in PSP circadian dysfunction is the disconnection between SCN and pineal gland:
graph LR
A["SCN"] -->|"multisynaptic pathway"| B["Pineal Gland"]
B --> C["Melatonin Secretion"]
C --> D["Peripheral Clock Synchronization"]
C --> E["Sleep Enhancement"]
C --> F["Glymphatic Clearance"]
G["Tau Pathology in PSP"] --> H["SCN Neuronal Loss"]
G --> I["Pineal Dysfunction"]
H --> J["Reduced SCN Output"]
I --> K["Impaired Melatonin Rhythm"]
J --> L["Circadian Desynchronization"]
K --> L
Circadian dysfunction in PSP produces cascading effects:
-
Sleep-wake fragmentation
- Reduced sleep efficiency
- Frequent nocturnal awakenings
- Daytime sleepiness and napping
-
Body temperature dysregulation
- Reduced amplitude of temperature rhythm
- Impaired nighttime dip
- Altered thermoregulatory responses
-
Hormonal dysregulation
- Cortisol rhythm flattening
- Growth hormone alterations
- Reduced melatonin effects on peripheral tissues
-
Cognitive impairment exacerbation
- SCN output to prefrontal cortex disrupted
- Executive function further compromised
- Attention and vigilance impaired
| Feature |
Prevalence in PSP |
Impact |
| Sleep onset insomnia |
40-60% |
Delayed sleep onset |
| Sleep fragmentation |
60-80% |
Frequent awakenings |
| Early morning awakening |
30-50% |
Advanced sleep phase |
| Excessive daytime sleepiness |
40-70% |
Napping during day |
| REM sleep behavior disorder |
10-20% |
Sleep-enacting behaviors |
Circadian dysfunction affects the temporal pattern of PSP symptoms:
- Morning worsening — motor and cognitive symptoms worse in morning hours
- Afternoon improvement — some patients show afternoon "on" periods
- Evening phenomenon — sunset can trigger symptom exacerbation
- Nocturnal agitation — sundowning-like phenomenon
| Feature |
PSP |
PD |
MSA |
CBS |
| Circadian dysfunction severity |
+++ |
++ |
+++ |
++ |
| Melatonin reduction |
+++ |
++ |
++ |
+ |
| SCN vulnerability |
High |
Moderate |
High |
Moderate |
| Sleep fragmentation |
Severe |
Moderate |
Severe |
Moderate |
Circadian function assessment may aid PSP diagnosis:
| Marker |
Assessment Method |
Utility |
| Dim light melatonin onset (DLMO) |
Serial saliva sampling |
Research |
| Core body temperature rhythm |
Continuous monitoring |
Research |
| Actigraphy patterns |
Wearable monitoring |
Clinical |
| Cortisol rhythm |
Serial serum sampling |
Research |
| Melatonin metabolite levels |
Urine/serum 6-SMT |
Emerging |
PSP patients can be classified by circadian phenotype:
- Advanced sleep phase — early evening sleep, early morning awakening
- Irregular sleep-wake — no consistent pattern
- Fragmented rhythm — multiple short sleep episodes
- Relative preservation — intact circadian organization (minority)
-
Light therapy
- Bright light exposure in morning
- Light avoidance in evening
- Timing critical for entrainment
-
Melatonin supplementation
- Evening melatonin administration
- Dose: 0.5-5 mg at bedtime
- May improve sleep and reduce sundowning[^hood2014]
-
Sleep hygiene optimization
- Consistent sleep-wake schedule
- Temperature control in bedroom
- Darkness maximization at night
-
Pharmacological approaches
- Ramelteon (melatonin agonist)
- Tasimelteon (circadian stabilizer)
- Suvorexant (orexin antagonist for sleep onset)
-
Lifestyle modifications
- Regular exercise timing
- Meal timing consistency
- Avoiding evening light exposure
- Can circadian biomarkers predict PSP progression?
- Does treating circadian dysfunction slow disease progression?
- What is the relationship between SCN pathology and cognitive decline in PSP?
- Can chronotherapy improve PSP clinical outcomes?
- Melatonin supplementation trials in PSP (ongoing)
- Light therapy feasibility studies
- Circadian rhythm assessment in clinical trial endpoints
Related pages in NeuroWiki: